Filing Details

Accession Number:
0001144204-19-027313
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-20 16:32:16
Reporting Period:
2019-05-17
Accepted Time:
2019-05-20 16:32:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1023024 Ani Pharmaceuticals Inc ANIP Pharmaceutical Preparations (2834) 582301143
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579587 G. James Marken C/O Ani Pharmaceuticals, Inc.
210 Main Street West
Baudette MN 56623
Svp Ops & Prod Dev No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-05-17 8,907 $70.67 61,230 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares were sold in multiple trades at prices ranging from $70.50 to $71.00. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.